EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning
- 1 January 2007
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 48 (2) , 256-269
Abstract
The use of reduced intensity regimens has decreased early mortality following stem cell transplantation. However, the increased immunosuppression following these protocols results in profound and often prolonged lymphopenia, resulting in an increased incidence of viral reactivation. We and others have observed a high incidence of EBV viraemia and post-transplant lymphoproliferative disease (PTLD) following reduced-intensity conditioning regimens, reflecting the delayed recovery of EBV-specific immunity after such transplants. The clinical and histological features at presentation are similar to that seen after conventional intensity conditioning. Given the increasing use of reduced intensity conditioning (RIC) transplants, we review the risk factors for EBV related disease following transplantation with RIC, the potential for pre-emptive therapy of PTLD based on monitoring EBV viraemia and management options in such patients.Keywords
This publication has 59 references indexed in Scilit:
- Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantationBlood, 2006
- Increased incidence of EBV‐related disease following paediatric stem cell transplantation with reduced‐intensity conditioningBritish Journal of Haematology, 2005
- Prompt versus preemptive intervention for EBV lymphoproliferative diseaseBlood, 2004
- Impaired recovery of Epstein-Barr virus (EBV)—specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative diseaseBlood, 2003
- Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipientsTransplantation and Cellular Therapy, 2001
- Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experienceBone Marrow Transplantation, 1998
- Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)Springer Seminars in Immunopathology, 1998
- Cytotoxic T lymphocyte responses to Epstein-Barr virusCurrent Opinion in Immunology, 1996
- Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative diseaseBritish Journal of Haematology, 1995
- INCREASED FREQUENCY OF POSTTRANSPLANT LYMPHOMAS IN PATIENTS TREATED WITH CYCLOSPORINE, AZATHIOPRINE, AND PREDNISONETransplantation, 1989